Ongoing phase 2 agents for multiple sclerosis: could we break the phase 3 trial deadlock?
Saved in:
| Title: | Ongoing phase 2 agents for multiple sclerosis: could we break the phase 3 trial deadlock? |
|---|---|
| Authors: | Susin-Calle S; Department of Neurology, Hospital del Mar Research Institute and Pompeu Fabra University, Barcelona, Spain., Martinez-Rodriguez JE; Department of Neurology, Hospital del Mar Research Institute and Pompeu Fabra University, Barcelona, Spain., Munteis E; Department of Neurology, Hospital del Mar Research Institute and Pompeu Fabra University, Barcelona, Spain., Villoslada P; Department of Neurology, Hospital del Mar Research Institute and Pompeu Fabra University, Barcelona, Spain. |
| Source: | Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2025 Mar; Vol. 34 (3), pp. 217-229. Date of Electronic Publication: 2025 Feb 28. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7658 (Electronic) Linking ISSN: 13543784 NLM ISO Abbreviation: Expert Opin Investig Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1744-7658 |
|---|---|
| DOI: | 10.1080/13543784.2025.2472240 |
